Published in Biotechnol Appl Biochem on June 01, 1996
Crystallization and preliminary crystallographic analysis of human common-type acylphosphatase. Acta Crystallogr Sect F Struct Biol Cryst Commun (2005) 0.81
Acylphosphatase possesses nucleoside triphosphatase and nucleoside diphosphatase activities. Biochem J (2000) 0.79
Designing conditions for in vitro formation of amyloid protofilaments and fibrils. Proc Natl Acad Sci U S A (1999) 4.71
Lymphoproliferative disorder and imbalanced T-helper response in C/EBP beta-deficient mice. EMBO J (1995) 3.48
The intriguing role of polymorphonuclear neutrophils in antitumor reactions. Blood (2001) 2.92
Mutational analysis of acylphosphatase suggests the importance of topology and contact order in protein folding. Nat Struct Biol (1999) 2.34
Kallikrein-kinin system in inflammatory bowel diseases: Intestinal involvement and correlation with the degree of tissue inflammation. Dig Liver Dis (2005) 2.18
Interleukin 12-mediated prevention of spontaneous mammary adenocarcinomas in two lines of Her-2/neu transgenic mice. J Exp Med (1998) 2.08
The crystal structure of a low-molecular-weight phosphotyrosine protein phosphatase. Nature (1994) 1.95
Mutational analysis of the propensity for amyloid formation by a globular protein. EMBO J (2000) 1.86
The natural history of asymptomatic hepatitis B surface antigen carriers. Ann Intern Med (1993) 1.79
Acceleration of the folding of acylphosphatase by stabilization of local secondary structure. Nat Struct Biol (1999) 1.66
Assessment of thrombin-activatable fibrinolysis inhibitor (TAFI) plasma levels in inflammatory bowel diseases. Am J Gastroenterol (2004) 1.59
The production and characterization of monoclonal antibodies to a human colonic antigen associated with ulcerative colitis: cellular localization of the antigen by using the monoclonal antibody. J Immunol (1987) 1.58
Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement. Dig Liver Dis (2005) 1.57
Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients. Gut (2003) 1.56
An open-label trial of levetiracetam in severe myoclonic epilepsy of infancy. Neurology (2007) 1.56
Decrease of intraocular pressure after subconjunctival injection of mitomycin in human glaucoma. Arch Ophthalmol (1995) 1.51
Coexpression of IL-6 and soluble IL-6R causes nodular regenerative hyperplasia and adenomas of the liver. EMBO J (1998) 1.50
5-fluorouracil in combined trabeculectomy and clear-cornea phacoemulsification with posterior chamber intraocular lens implantation. A one-year randomized, controlled clinical trial. Ophthalmology (1997) 1.44
Establishment and characterization of a human neuroblastoma cell line. Int J Cancer (1989) 1.43
The role of individual SH2 domains in mediating association of phospholipase C-gamma1 with the activated EGF receptor. J Biol Chem (1999) 1.43
Local cytokine availability elicits tumor rejection and systemic immunity through granulocyte-T-lymphocyte cross-talk. Cancer Res (1992) 1.39
Analysis of mammary carcinoma onset and progression in HER-2/neu oncogene transgenic mice reveals a lobular origin. Lab Invest (1999) 1.37
Group B streptococci persist inside macrophages. Immunology (1998) 1.36
Functional and ethnic association of allele 2 of the interleukin-1 receptor antagonist gene in ulcerative colitis. Gastroenterology (1999) 1.35
Insights into acylphosphatase structure and catalytic mechanism. Cell Mol Life Sci (1997) 1.32
Two vicinal cysteines confer a peculiar redox regulation to low molecular weight protein tyrosine phosphatase in response to platelet-derived growth factor receptor stimulation. J Biol Chem (2001) 1.32
Antitumor efficacy of adenocarcinoma cells engineered to produce interleukin 12 (IL-12) or other cytokines compared with exogenous IL-12. J Natl Cancer Inst (1997) 1.30
A shared and unique epitope(s) on human colon, skin, and biliary epithelium detected by a monoclonal antibody. Gastroenterology (1990) 1.28
Slow folding of muscle acylphosphatase in the absence of intermediates. J Mol Biol (1998) 1.26
Physiological requirement for both SH2 domains for phospholipase C-gamma1 function and interaction with platelet-derived growth factor receptors. Mol Cell Biol (1999) 1.26
Three-dimensional structure of acylphosphatase. Refinement and structure analysis. J Mol Biol (1992) 1.24
Early-onset seizure variant of Rett syndrome: definition of the clinical diagnostic criteria. Brain Dev (2009) 1.23
Chronic unexplained hypertransaminasemia may be caused by occult celiac disease. Hepatology (1999) 1.23
Cystine accumulation and clearance by normal and cystinotic leukocytes exposed to cystine dimethyl ester. Proc Natl Acad Sci U S A (1982) 1.21
A partially structured species of beta 2-microglobulin is significantly populated under physiological conditions and involved in fibrillogenesis. J Biol Chem (2001) 1.19
Redox regulation of anoikis: reactive oxygen species as essential mediators of cell survival. Cell Death Differ (2008) 1.18
Role of neutrophils and CD4+ T lymphocytes in the primary and memory response to nonimmunogenic murine mammary adenocarcinoma made immunogenic by IL-2 gene. J Immunol (1992) 1.15
Low molecular weight protein tyrosine phosphatases: small, but smart. Cell Mol Life Sci (2002) 1.15
Inhibition of tumor growth and enhancement of metastasis after transfection of the gamma-interferon gene. Int J Cancer (1993) 1.15
Conformational stability of muscle acylphosphatase: the role of temperature, denaturant concentration, and pH. Biochemistry (1998) 1.13
Crystal structure of common type acylphosphatase from bovine testis. Structure (1997) 1.13
Redox regulation of anoikis resistance of metastatic prostate cancer cells: key role for Src and EGFR-mediated pro-survival signals. Oncogene (2009) 1.13
Structural characterization of the transition state for folding of muscle acylphosphatase. J Mol Biol (1998) 1.13
The inactivation mechanism of low molecular weight phosphotyrosine-protein phosphatase by H2O2. J Biol Chem (1998) 1.11
HTLV-V: a new human retrovirus isolated in a Tac-negative T cell lymphoma/leukemia. Science (1987) 1.10
Expression, purification, and characterization of acylphosphatase muscular isoenzyme as fusion protein with glutathione S-transferase. Protein Expr Purif (1995) 1.09
Biliary cystadenoma: an uncommon cause of recurrent cholestatic jaundice. Am J Gastroenterol (1986) 1.09
IL-6 expression in neurons of transgenic mice causes reactive astrocytosis and increase in ramified microglial cells but no neuronal damage. Eur J Neurosci (1995) 1.08
Cardiac growth factors in human hypertrophy. Relations with myocardial contractility and wall stress. Circ Res (1999) 1.08
Inactivation of the IL-6 gene prevents development of multicentric Castleman's disease in C/EBP beta-deficient mice. J Exp Med (1996) 1.08
Interleukin 2 activated tumor inhibition in vivo depends on the systemic involvement of host immunoreactivity. J Immunol (1987) 1.07
Mmf1p, a novel yeast mitochondrial protein conserved throughout evolution and involved in maintenance of the mitochondrial genome. Mol Cell Biol (2000) 1.06
Decrease of proliferation rate and induction of differentiation by a MYCN antisense DNA oligomer in a human neuroblastoma cell line. Cell Growth Differ (1991) 1.05
The role of Cys12, Cys17 and Arg18 in the catalytic mechanism of low-M(r) cytosolic phosphotyrosine protein phosphatase. Eur J Biochem (1993) 1.04
Identification and characterization of the product encoded by ORF69 of Kaposi's sarcoma-associated herpesvirus. J Virol (2008) 1.04
Clinical trial: ulcerative colitis maintenance treatment with 5-ASA: a 1-year, randomized multicentre study comparing MMX with Asacol. Aliment Pharmacol Ther (2009) 1.03
High prevalence of Helicobacter pylori infection in patients with colonic adenomas and carcinomas. J Clin Gastroenterol (1997) 1.03
Some protein tyrosine phosphatases target in part to lipid rafts and interact with caveolin-1. Biochem Biophys Res Commun (2002) 1.03
Image enhancement via adaptive unsharp masking. IEEE Trans Image Process (2000) 1.03
Age-related clinical severity at diagnosis in 1705 patients with ulcerative colitis: a study by GISC (Italian Colon-Rectum Study Group). Dig Dis Sci (2000) 1.03
Low doses of IL-4 injected perilymphatically in tumor-bearing mice inhibit the growth of poorly and apparently nonimmunogenic tumors and induce a tumor-specific immune memory. J Immunol (1990) 1.02
A common repertoire of autoantibodies is shared by cancer and autoimmune disease patients: Inflammation in their induction and impact on tumor growth. Cancer Lett (2008) 1.02
Inhibitory effect of full-length human endostatin on in vitro angiogenesis. Biochem Biophys Res Commun (1999) 1.01
Type V collagen in human amnion is a 12 nm fibrillar component of the pericellular interstitium. Eur J Cell Biol (1984) 1.01
A "stealth effect": adenocarcinoma cells engineered to express TRAIL elude tumor-specific and allogeneic T cell reactions. J Immunol (1999) 1.01
Effect of a YAG laser iridotomy on intraocular pressure in pigment dispersion syndrome. Ophthalmology (1996) 1.00
Persistence of circulating HBsAg/IgM complexes in acute viral hepatitis, type B: an early marker of chronic evolution. Lancet (1982) 1.00
Familial aggregation of inflammatory bowel disease in northern Italy: a multicenter study. The Gruppo di Studio per le Malattie Infiammatorie Intestinali (IBD Study Group). Gastroenterology (1992) 1.00
PDGF receptor as a specific in vivo target for low M(r) phosphotyrosine protein phosphatase. FEBS Lett (1995) 1.00
Development of a monoclonal antibody specifically reactive to gastrointestinal goblet cells. Proc Natl Acad Sci U S A (1987) 1.00
Heterozygote detection in cystinosis, using leukocytes exposed to cystine dimethyl ester. N Engl J Med (1982) 0.99
The low M(r) protein-tyrosine phosphatase is involved in Rho-mediated cytoskeleton rearrangement after integrin and platelet-derived growth factor stimulation. J Biol Chem (2000) 0.99
Variants of OCTN1-2 cation transporter genes are associated with both Crohn's disease and ulcerative colitis. Aliment Pharmacol Ther (2006) 0.99
Role of neutrophils and lymphocytes in inhibition of a mouse mammary adenocarcinoma engineered to release IL-2, IL-4, IL-7, IL-10, IFN-alpha, IFN-gamma, and TNF-alpha. Lab Invest (1996) 0.99
p-ANCA and development of pouchitis in ulcerative colitis patients after proctocolectomy and ileoanal pouch anastomosis. Lancet (1994) 0.98
Cytokines, tumour-cell death and immunogenicity: a question of choice. Immunol Today (1997) 0.98
Aspartic-129 is an essential residue in the catalytic mechanism of the low M(r) phosphotyrosine protein phosphatase. FEBS Lett (1994) 0.97
Changes in Enzyme Levels During Germination of Seeds of Triticum durum. Plant Physiol (1968) 0.97
Death of bystander cells by a novel pathway involving early mitochondrial damage in human immunodeficiency virus-related lymphadenopathy. Blood (1997) 0.97
Stabilisation of alpha-helices by site-directed mutagenesis reveals the importance of secondary structure in the transition state for acylphosphatase folding. J Mol Biol (2000) 0.97
Nitric oxide causes inactivation of the low molecular weight phosphotyrosine protein phosphatase. J Biol Chem (1994) 0.97
High prevalence of hyperchomocysteinemia in patients with inflammatory bowel disease: a pathogenic link with thromboembolic complications? Thromb Haemost (1998) 0.96
Use of the Given Patency System for the screening of patients at high risk for capsule retention. Dig Liver Dis (2006) 0.96
An efficient Th2-type memory follows CD8+ lymphocyte-driven and eosinophil-mediated rejection of a spontaneous mouse mammary adenocarcinoma engineered to release IL-4. J Immunol (1994) 0.95
5-Fluorocytosine-induced eradication of murine adenocarcinomas engineered to express the cytosine deaminase suicide gene requires host immune competence and leaves an efficient memory. J Immunol (1995) 0.95
c-Src activates both STAT1 and STAT3 in PDGF-stimulated NIH3T3 cells. Biochem Biophys Res Commun (1997) 0.95
Horse muscle acyl phosphatase: purification and some properties. Arch Biochem Biophys (1969) 0.94
Dephosphorylation of tyrosine phosphorylated synthetic peptides by rat liver phosphotyrosine protein phosphatase isoenzymes. FEBS Lett (1993) 0.94
Looking for residues involved in the muscle acylphosphatase catalytic mechanism and structural stabilization: role of Asn41, Thr42, and Thr46. Biochemistry (1996) 0.94
Nonenzymatic acetylation of histones with acetyl phosphate and acetyl adenylate. Biochemistry (1975) 0.93
A new synthesis of benzoyl phosphate: a substrate for acyl phosphatase assay. Experientia (1976) 0.92
Reduction of the amyloidogenicity of a protein by specific binding of ligands to the native conformation. Protein Sci (2001) 0.92